|
CH575014A5
(enExample)
|
1973-05-25 |
1976-04-30 |
Alusuisse |
|
|
JPS5328498Y2
(enExample)
|
1973-08-17 |
1978-07-18 |
|
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
BR9204244A
(pt)
|
1992-10-26 |
1994-05-03 |
Cofap |
Ferro fundido cinzento
|
|
CA2149025A1
(en)
|
1992-12-01 |
1994-06-09 |
Man Sung Co |
Humanized antibodies reactive with l-selectin
|
|
FR2707189B1
(fr)
|
1993-07-09 |
1995-10-13 |
Gradient Ass |
Procédé de traitement de résidus de combustion et installation de mise en Óoeuvre dudit procédé.
|
|
FR2729855A1
(fr)
|
1995-01-26 |
1996-08-02 |
Oreal |
Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
|
|
US5876950A
(en)
|
1995-01-26 |
1999-03-02 |
Bristol-Myers Squibb Company |
Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy
|
|
AU690474B2
(en)
|
1995-09-11 |
1998-04-23 |
Kyowa Hakko Kirin Co., Ltd. |
Antibody againts alpha-chain of human interleukin 5 receptor
|
|
EP0852951A1
(de)
|
1996-11-19 |
1998-07-15 |
Roche Diagnostics GmbH |
Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
|
|
CN1241944A
(zh)
|
1996-12-05 |
2000-01-19 |
乔治敦大学 |
具有抗病毒活性的鼠尾草种类的提取物
|
|
JPH11101542A
(ja)
|
1997-09-29 |
1999-04-13 |
Sanyo Electric Co Ltd |
冷蔵庫
|
|
AU3657899A
(en)
|
1998-04-20 |
1999-11-08 |
James E. Bailey |
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
|
|
CN101070344A
(zh)
|
1998-04-30 |
2007-11-14 |
泰诺士公司 |
G－csf受体兴奋剂抗体及其筛选方法
|
|
FR2780062B1
(fr)
|
1998-06-17 |
2000-07-28 |
Rhone Poulenc Rorer Sa |
Anticorps monoclonaux diriges contre la proteine g3bp, et leurs utilisations
|
|
WO1999067290A1
(fr)
|
1998-06-24 |
1999-12-29 |
Chugai Research Institute For Molecular Medicine, Inc. |
Nouvelles proteines receptrices d'hemopoïetine
|
|
EP1051432B1
(en)
|
1998-12-08 |
2007-01-24 |
Biovation Limited |
Method for reducing immunogenicity of proteins
|
|
PT1176195E
(pt)
|
1999-04-09 |
2013-07-18 |
Kyowa Hakko Kirin Co Ltd |
Processo para controlar a actividade de uma molécula funcional sob o ponto de vista imunológico
|
|
EP2135953B1
(en)
|
1999-06-02 |
2014-04-23 |
Chugai Seiyaku Kabushiki Kaisha |
Novel hemopoietin receptor protein, Nr. 10
|
|
ES2254224T3
(es)
|
1999-09-27 |
2006-06-16 |
Chugai Seiyaku Kabushiki Kaisha |
Nueva proteina del receptor de hematopoyetina, nr12.
|
|
CN1326880A
(zh)
|
2000-06-06 |
2001-12-19 |
周伟中 |
双层站台火车站
|
|
WO2002000721A2
(en)
|
2000-06-26 |
2002-01-03 |
Zymogenetics, Inc. |
Cytokine receptor zcytor17
|
|
US20030096339A1
(en)
|
2000-06-26 |
2003-05-22 |
Sprecher Cindy A. |
Cytokine receptor zcytor17
|
|
JP5291279B2
(ja)
|
2000-09-08 |
2013-09-18 |
ウニヴェルジテート・チューリッヒ |
反復モジュールを含む反復タンパク質の集合体
|
|
EP2141243A3
(en)
|
2000-10-16 |
2010-01-27 |
Brystol-Myers Squibb Company |
Protein scaffolds for antibody mimics and other binding proteins
|
|
WO2002077230A1
(fr)
|
2001-03-26 |
2002-10-03 |
Chugai Seiyaku Kabushiki Kaisha |
Variants d'epissage nr10
|
|
ATE412013T1
(de)
|
2001-04-05 |
2008-11-15 |
Immuno Biological Lab Co Ltd |
Anti-osteopontin-antikörper und dessen verwendung
|
|
US20030157561A1
(en)
|
2001-11-19 |
2003-08-21 |
Kolkman Joost A. |
Combinatorial libraries of monomer domains
|
|
ES2382800T3
(es)
|
2002-01-18 |
2012-06-13 |
Zymogenetics, Inc. |
Multímeros Zcytor17 receptores de citocinas
|
|
ES2377188T3
(es)
|
2002-01-18 |
2012-03-23 |
Zymogenetics, Inc. |
Nuevo ligando de citocina ZCYTOR17
|
|
EP2110434A1
(en)
|
2002-02-25 |
2009-10-21 |
Genentech, Inc. |
Type-1 cytokine receptor GLM-R
|
|
HK1080372A1
(zh)
|
2002-05-01 |
2006-04-28 |
Schering Aktiengesellschaft |
作为抗凝剂的新型组织因子目标抗体
|
|
US7579000B2
(en)
|
2002-05-01 |
2009-08-25 |
Bayer Schering Pharma Ag |
Tissue factor targeted antibodies as anticoagulants
|
|
TW200407335A
(en)
|
2002-07-22 |
2004-05-16 |
Chugai Pharmaceutical Co Ltd |
Non-neutralizing antibody to inhibit the inactivation of activated protein C
|
|
KR100499989B1
(ko)
|
2002-12-27 |
2005-07-07 |
네오바이오다임 주식회사 |
아사이알로 α1-산 당단백질에 대한 단일클론 항체, 이 항체를 포함하는 아사이알로 α1-산 당단백질에 대한 단일클론 항체, 이 항체를 포함하는 면역크로마토그래피 스트립 및 이 스트립를 이용한 아사이알로 α1-산 당단백질 측정방법
|
|
US20040223970A1
(en)
|
2003-02-28 |
2004-11-11 |
Daniel Afar |
Antibodies against SLC15A2 and uses thereof
|
|
EP1605974B1
(en)
|
2003-03-04 |
2014-11-12 |
Alexion Pharmaceuticals, Inc. |
Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
|
|
EP1606317B1
(en)
|
2003-03-24 |
2010-07-28 |
ZymoGenetics, Inc. |
Anti-il-22ra antibodies and binding partners and methods of using in inflammation
|
|
AU2005213965B2
(en)
|
2004-02-12 |
2009-11-19 |
Lexicon Pharmaceuticals, Inc. |
Gene disruptions, compositions and methods relating thereto
|
|
US20060019342A1
(en)
|
2004-06-25 |
2006-01-26 |
Medimmune, Inc. |
Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis
|
|
KR100624013B1
(ko)
|
2004-06-25 |
2006-09-19 |
주식회사 녹십자홀딩스 |
동결건조된 알부민 비함유 재조합 사람 혈액응고 제 8인자 제제
|
|
EP1671642A1
(en)
|
2004-12-15 |
2006-06-21 |
Universite D'angers |
Compositions comprising (ant)agonists of oncostatin M (OSM), IL-31 and IFN-gamma for modulating keratinocyte migration and functions via a receptor containing OSMRbeta as a subunit, and applications thereof.
|
|
EP1831258B2
(en)
|
2004-12-28 |
2023-06-07 |
Innate Pharma S.A. |
Monoclonal antibodies against nkg2a
|
|
WO2006081573A2
(en)
|
2005-01-28 |
2006-08-03 |
Zymogenetics, Inc. |
Homogeneous preparations of il-31
|
|
WO2006088855A1
(en)
|
2005-02-14 |
2006-08-24 |
Zymogenetics, Inc. |
Methods of treating skin disorders using an il-31ra antagonist
|
|
JP4927762B2
(ja)
|
2005-02-14 |
2012-05-09 |
ザイモジェネティクス， インコーポレイテッド |
Ｉｌ−３１アンタゴニストに対するアトピー性皮膚炎の治療応答を予測する方法
|
|
PE20061323A1
(es)
|
2005-04-29 |
2007-02-09 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos
|
|
US8003108B2
(en)
|
2005-05-03 |
2011-08-23 |
Amgen Inc. |
Sclerostin epitopes
|
|
BRPI0611069A2
(pt)
*
|
2005-05-06 |
2010-11-09 |
Zymogenetics Inc |
anticorpo monoclonal, anticorpo humanizado, fragmento de anticorpo, uso de um antagonista, e, hibridoma
|
|
RU2444528C2
(ru)
|
2005-05-06 |
2012-03-10 |
Займоджинетикс, Инк. |
Моноклональные антитела против il-31 и способы применения
|
|
AU2007249713A1
(en)
|
2006-01-10 |
2007-11-22 |
Zymogenetics, Inc. |
Methods of treating pain and inflammation in neuronal tissue using IL-31Ra and OSMRb antagonists
|
|
US8075884B2
(en)
|
2006-01-12 |
2011-12-13 |
Alexion Pharmaceuticals, Inc. |
Antibodies to OX-2/CD200 and uses thereof
|
|
BRPI0709050B1
(pt)
|
2006-03-23 |
2018-12-26 |
Bioarctic Neuroscience Ab |
anticorpo ou fragmento do mesmo, composição, métodos para detectar protofibrilas ab in vitro, e, uso do anticorpo
|
|
DK2047863T3
(da)
|
2006-06-08 |
2013-09-16 |
Chugai Pharmaceutical Co Ltd |
Middel til forebyggelse eller behandling af inflammatoriske sygdomme
|
|
WO2007147122A2
(en)
|
2006-06-15 |
2007-12-21 |
The Board Of Trustees Of The University Of Arkansas |
Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine like compounds
|
|
CN103044550A
(zh)
|
2006-09-01 |
2013-04-17 |
津莫吉尼蒂克斯公司 |
Il-31单克隆抗体的可变区序列和使用方法
|
|
WO2008073463A2
(en)
|
2006-12-11 |
2008-06-19 |
Wyeth |
Methods and compositions for treating and monitoring treatment of il-13-associated disorders
|
|
CN101600456A
(zh)
*
|
2006-12-11 |
2009-12-09 |
惠氏公司 |
治疗il-13相关疾病和监测il-13相关疾病治疗的方法和组合物
|
|
DE602008004296D1
(de)
|
2007-02-14 |
2011-02-17 |
Vaccinex Inc |
Humanisierte anti-cd100-antikörper
|
|
DK2426144T3
(en)
|
2007-02-23 |
2019-01-07 |
Merck Sharp & Dohme |
Manipulated Anti-IL-23P19 Antibodies
|
|
JPWO2008114733A1
(ja)
|
2007-03-16 |
2010-07-01 |
協和発酵キリン株式会社 |
抗Ｃｌａｕｄｉｎ−４抗体
|
|
GB0708002D0
(en)
|
2007-04-25 |
2007-06-06 |
Univ Sheffield |
Antibodies
|
|
CA2693611A1
(en)
|
2007-07-10 |
2009-01-15 |
F. Hoffmann-La Roche Ag |
Novel formulation
|
|
CN101939425B
(zh)
|
2007-09-26 |
2014-05-14 |
中外制药株式会社 |
抗il-6受体抗体
|
|
CN101874042B9
(zh)
*
|
2007-09-26 |
2019-01-01 |
中外制药株式会社 |
利用cdr的氨基酸取代来改变抗体等电点的方法
|
|
EP3415529B1
(en)
|
2007-09-26 |
2020-11-04 |
Chugai Seiyaku Kabushiki Kaisha |
Modified antibody constant region
|
|
BRPI0821110B8
(pt)
|
2007-12-05 |
2021-05-25 |
Chugai Pharmaceutical Co Ltd |
anticorpo de neutralização de anti-nr10/il31ra, composição farmacêutica compreendendo o referido anticorpo e uso do mesmo
|
|
WO2009072598A1
(ja)
|
2007-12-05 |
2009-06-11 |
Chugai Seiyaku Kabushiki Kaisha |
掻痒症治療剤
|
|
KR101603109B1
(ko)
|
2007-12-07 |
2016-03-25 |
지모제넥틱스, 인코포레이티드 |
Ｉｌ-31에 특이적인 인간화된 항체 분자
|
|
KR20160062207A
(ko)
|
2008-12-05 |
2016-06-01 |
추가이 세이야쿠 가부시키가이샤 |
항ｎｒ１０ 항체 및 그의 이용
|
|
JP2010210772A
(ja)
|
2009-03-13 |
2010-09-24 |
Dainippon Screen Mfg Co Ltd |
液晶表示装置の製造方法
|
|
EP2475376B1
(en)
|
2009-06-17 |
2016-03-30 |
BioMarin Pharmaceutical Inc. |
Formulations for lysosomal enzymes
|
|
WO2013012022A1
(ja)
|
2011-07-19 |
2013-01-24 |
中外製薬株式会社 |
アルギニンアミドまたはその類似化合物を含む安定なタンパク質含有製剤
|
|
US8790651B2
(en)
*
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
KR102576903B1
(ko)
|
2012-09-07 |
2023-09-13 |
리제너론 파아마슈티컬스, 인크. |
Ｉｌ-4ｒ 길항제 투여로 아토피성 피부염을 치료하는 방법
|
|
EP2970508A4
(en)
|
2013-03-15 |
2016-12-14 |
Permeon Biologics Inc |
GENETICALLY MODIFIED LOADING ANTIBODIES OR ENHANCED ENHANCEMENT ENHANCEMENT TARGETING PROTEIN COMPOSITIONS AND METHODS OF USE
|
|
US9198898B2
(en)
*
|
2013-06-24 |
2015-12-01 |
Tigercat Pharma, Inc. |
Use of NK-1 receptor antagonists in pruritus
|
|
TW201537175A
(zh)
*
|
2013-06-28 |
2015-10-01 |
Chugai Pharmaceutical Co Ltd |
預測罹患具皮膚搔癢之疾病的患者對ｉｌ－３１拮抗劑之治療的反應之方法
|
|
CA2980992C
(en)
|
2015-04-14 |
2024-01-23 |
Akihisa Kaneko |
Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing il-31 antagonist as active ingredient
|
|
GB201703063D0
(en)
|
2017-02-24 |
2017-04-12 |
Arecor Ltd |
Stabilized antibody protein solutions
|
|
WO2018156367A1
(en)
|
2017-02-24 |
2018-08-30 |
Kindred Biosciences, Inc. |
Anti-il31 antibodies for veterinary use
|
|
US10554227B2
(en)
*
|
2017-03-10 |
2020-02-04 |
Western Digital Technologies, Inc. |
Decoding optimization for channel mismatch
|
|
BR112019021364A2
(pt)
|
2017-04-11 |
2020-05-05 |
Kiniksa Phamaceuticals Ltd |
formulação estável de anticorpo anti-osmr
|
|
US20210196568A1
(en)
|
2018-05-21 |
2021-07-01 |
Chugai Seiyaku Kabushiki Kaisha |
Lyophilized formulation sealed in glass container
|
|
JP6845973B1
(ja)
|
2019-11-20 |
2021-03-24 |
中外製薬株式会社 |
抗体含有製剤
|
|
EP4209227A4
(en)
|
2020-09-01 |
2024-05-29 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical composition for prevention and/or treatment of dialysis pruritus containing il-31 antagonist as active ingredient
|
|
JPWO2022113316A1
(enExample)
|
2020-11-30 |
2022-06-02 |
|
|
|
EP4455163A4
(en)
|
2021-12-22 |
2025-12-24 |
Chugai Pharmaceutical Co Ltd |
REDUCED BIOLOGICALLY ACTIVE ANTIBODY VARIANT
|